TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 4,950.00
-80.00 (-1.59%)
At close: Aug 11, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 148.69 billion as of August 12, 2026. Its market cap has increased by 19.91% in one year.
Market Cap
148.69B
Enterprise Value
152.80B
Revenue
13.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,950.00
ChartMarket Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 148.69B, a decrease of -52.33%. That is a compound annual growth rate of -10.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 148.69B | -12.83% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 217.57B |
| Kanaph Therapeutics | 200.71B |
| NIBEC | 194.39B |
| Y-Biologics | 174.10B |
| Bio Solution | 161.79B |
| Prestige Biologics | 154.26B |
| ISU Abxis | 144.95B |
| Ensol Biosciences | 140.74B |